3352.0 Biotechnology, Women's Health and Reproductive Rights: Policy Domestically and Internationally

Monday, November 5, 2007: 2:30 PM
This session will describe the current situation in the US related to new genetic and reproductive technologies, which are accelerating faster than public debate can keep up with. The session includes discussion of ethical, health and political considerations of new biotechnologies and the need to reconsider issues of privacy and individual autonomy. Panelists discuss the need to have a public discussion about the issues without appearing to side with opponents. The panelists describe the policy context and articulate the need to use a reproductive justice framework and public health perspectives to inform the debate and the policy process.
Session Objectives: At the end of the session participants will be able to: 1. Assess the implications of new biotechnologies for women's reproductive rights 2. Recognize the current state of policy in the US regarding new genetic and reproductive technologies 3. Identify women's health and social justice concerns and understand the current political debate within the reproductive rights movement regarding new biotechnologies 4. Define a reproductive justice perspective of the ethical, health and political considerations of new biotechnologies 5. Articulate a public health and reproductive justice perspective on policy promotion regarding new biotechnologies 6. Recognize the importance of using a reproductive justice model to promote the health and rights of women and how to use the model

3:14 PM
Global Human Rights and Reproductive Health
George Annas, JD, MPH and Jamie Brooks, JD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Population, Family Planning, and Reproductive Health
Endorsed by: Women's Caucus, Maternal and Child Health, HIV/AIDS

CE Credits: CME, Health Education (CHES), Nursing